The online version of this article (doi:10.1186/s12890-015-0062-7) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
HGA, AB, JSL, DR, LL, SR and DN participated in the study design. HGA, JB, EM collected the data. HGA, AB, JSL, EM and DN analysed the data. HGA. AB, JSL, DR, SR and DN participated in the draft of the manuscript. All authors read and approved the final manuscript.
Staphylococcus aureus (SA) is the most prevalent organism infecting the respiratory tract of CF children, and remains the second most prevalent organism in CF adults. During early childhood, SA infections are associated with pulmonary inflammation and decline in FEV1, but their clinical significance in adult CF patients is poorly characterized.
We conducted a retrospective cross-sectional study to determine the association between airway microbiology and clinical outcomes (FEV1, rate of pulmonary exacerbations, CRP levels and clinical scores).
In a cohort of 84 adult CF patients, 24 % were infected with SA only, 60 % were infected with PA, and 16 % had neither PA nor SA. CF patients with SA experienced fewer pulmonary exacerbations and lower CRP levels than those with PA.
In adult CF patients, SA infections alone, in the absence of PA, are a marker of milder disease.
Additional file 1: Table S1. Sputum microbiology for other microorganisms in sputum cultures12890_2015_62_MOESM1_ESM.pdf
(US) CFF. Patient Registry Annual Data Report 2012. Bethesda, Maryland: Cystic Fibrosis Foundation Patient Registry; 2012.
Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatrics. 2001;138(5):699–704. CrossRef
Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatric Pulmonol. 1999;28(5):321–8. CrossRef
Glikman D, Siegel JD, David MZ, Okoro NM, Boyle-Vavra S, Dowell ML, et al. Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus. Chest. 2008;133(6):1381–7. CrossRefPubMed
Goss CH, Muhlebach MS. Review: Staphylococcus aureus and MRSA in cystic fibrosis. J Cystic Fibrosis. 2011;10(5):298–306. CrossRef
Matouk E, Ghezzo RH, Gruber J, Hidvegi R, Gray-Donald K. Internal consistency reliability and predictive validity of a modified N. Huang clinical scoring system in adult cystic fibrosis patients. Eur Res J. 1997;10(9):2004–13. CrossRef
Dalboge CS, Pressler T, Hoiby N, Nielsen KG, Johansen HK. A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF. J Cystic Fibrosis. 2013;12(1):42–8. CrossRef
Kerem E, Viviani L, Zolin A, Macneill S, Hatziagorou E, Ellemunter H, et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the data of the ECFS Patient Registry. Eur Respir J. 2014;43(1):125–33.
Dasenbrook Ec CW. ASsociation between respiratory tract methicillin-resistant staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010;303(23):2386–92.
Dasenbrook EC. Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis. Curr Opin Pulm Med. 2011;17(6):437–41. PubMed
Canadian Cystic Fibrosis Patient Registry 2012 Annual Data Report. Cystic Fibrosis Canada, Toronto, Ontario, Canada; 2012:1–34.
- Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients
Heather G. Ahlgren
Jennifer S. Landry
Larry C. Lands
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II